Antimicrobial Resistance Surveillance Market

Home Healthcare And Pharmaceutical Antimicrobial Resistance Surveillance Market

SPECIAL OFFER : 25% Super Discount For All !

Antimicrobial Resistance Surveillance Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Solution (Diagnostic Kits, Diagnostic Systems, Surveillance Software, Services); By Application (Clinical Diagnostics, Public Health Surveillance); By End User (Hospitals & Clinics, Research & Academic Institutes); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published Date: December 2023
Report ID: BWC231035
Available Format: PDF
Page: 400

Report Overview

Growing incidences of hospital-acquired infections driving the increasing adoption of innovative diagnostic techniques are projected to propel the expansion of the Global Antimicrobial Resistance Surveillance Market during the forecast period between 2023 and 2029.

Global Antimicrobial Resistance Surveillance Market - Industry Trends & Forecast Report, 2029

Global Antimicrobial Resistance Surveillance Market size was estimated at USD 5.71 billion in 2022. During the forecast period between 2023 and 2029, the size of Global Antimicrobial Resistance Surveillance Market is projected to grow at a CAGR of 5.6% reaching a value of USD 7.92 billion by 2029. Major growth drivers for the Global Antimicrobial Resistance Surveillance Market include increasing incidences of infections attributed to drug-resistant pathogens, advancements in diagnostic technologies, a rising concern over antimicrobial resistance, governmental efforts to address antimicrobial resistance, and the emergence of multi-drug resistance linked to drug abuse. Notably, advanced imaging technologies now deliver clinical information swiftly, contrasting with traditional culture-based methods taking up to 48 hours for susceptibility data. The Emergence Of New Techniques Detecting Drug Resistance Without Lengthy Culture processes shortens the diagnostic timeframe by at least a day. Faster and more advanced diagnostic tests are expected to drive the antimicrobial resistance diagnostics market. Also, nosocomial infections, acquired during hospitalization, encompass diverse illnesses. Hospital-acquired infections, such as central line-associated bloodstream infections and urinary tract infections from catheters, are widespread. The prevalence of these infections is poised to boost the antimicrobial resistance diagnostics market, reflecting the growing use of invasive techniques and equipment in modern healthcare.

Antimicrobial Resistance Surveillance Market

Antimicrobial Resistance Surveillance – Overview

Antimicrobial resistance (AMR) is a pressing public health issue, necessitating a robust global market. When microorganisms resist medications, treatment efficacy diminishes. The growing Global Antimicrobial Resistance Surveillance Market addresses the urgent need for surveillance systems to monitor AMR spread, enabling informed decisions on antibiotic prescriptions. Key components include advanced laboratory techniques, data analytics, and information-sharing platforms, collecting and analyzing global data. This approach empowers healthcare stakeholders to detect resistance patterns, implement targeted interventions, and innovate antimicrobial therapies.

Global Antimicrobial Resistance Surveillance Market

Growth Drivers

Increasing Incidences of Hospital-Acquired Infections

The escalating prevalence of hospital-acquired infections, commonly termed nosocomial infections, stands out as a crucial factor propelling the growth of the antimicrobial resistance diagnostics market. These infections encompass diverse types, including central line-associated bloodstream infections, urinary tract infections stemming from catheter use, various surgical site infections, ventilator-associated pneumonia, and infections caused by Clostridioides difficile (CD). The modern healthcare landscape, characterized by the application of invasive techniques and equipment, contributes significantly to the heightened occurrence of these infections. Consequently, the increasing incidences of hospital-acquired infections emerge as a noteworthy driver fostering the expansion of the antimicrobial resistance diagnostics market.

Restraints

High Costs associated with Antimicrobial Resistance Surveillance System and Kits

The Global Antimicrobial Resistance Surveillance Market growth faces a hindrance due to the substantial costs linked with surveillance systems and kits. The financial burden associated with implementing and maintaining these systems acts as a significant restraint, limiting widespread adoption. The high costs pose challenges for healthcare institutions and organizations aiming to invest in comprehensive antimicrobial resistance surveillance, thereby impacting the overall growth prospects of the market.

Impact of Covid-19 on Global Antimicrobial Resistance Surveillance Market

Covid-19 pandemic had a positive impact on Global Antimicrobial Resistance Surveillance Market. Several factors contributed to this exacerbation, including heightened antibiotic use for COVID-19 patients, disruptions in infection control measures within overwhelmed healthcare systems, and the redirection of resources away from monitoring and addressing antimicrobial resistance (AMR) threats. The pandemic necessitated the adoption of virtual visits and rapid diagnostic testing to minimize hospital visits. Even post-pandemic, home-based healthcare is expected to remain essential, particularly for individuals with pre-existing conditions, thereby fueling the demand for diagnostic assays.

Global Antimicrobial Resistance Surveillance Market

Segmental Coverage

Global Antimicrobial Resistance Surveillance Market – By Solution

Based on solution, the Global Antimicrobial Resistance Surveillance Market is divided into Diagnostic Kits, Diagnostic Systems, Surveillance Software, and Services segments. The diagnostics kits segment holds the highest share in the Global Antimicrobial Resistance Surveillance Market by solution. It is primarily due to the growing requirement for prompt identification and treatment, the escalating demand for swift diagnostics concerning antimicrobial resistance, and the necessity for essential data for the surveillance and monitoring of trends related to antimicrobial resistance.

Global Antimicrobial Resistance Surveillance Market – By Application

Based on application, the Global Antimicrobial Resistance Surveillance Market is bifurcated into Clinical Diagnostics and Public Health Surveillance segments. The clinical diagnostics segment holds a higher share in the Global Antimicrobial Resistance Surveillance Market by application. It can be attributed to the growing inclination toward improved patient outcomes and the rising prevalence of antimicrobial resistance.

Antimicrobial Resistance Surveillance Market Share

Global Antimicrobial Resistance Surveillance Market – By End User

On the basis of end user, the Global Antimicrobial Resistance Surveillance Market is split into Hospitals & Clinics and Research & Academic Institutes segments. The hospitals & clinics segment holds a higher share in the Global Antimicrobial Resistance Surveillance Market by end user, due to the elevated patient density observed in hospitals and clinics, the rising incidence of nosocomial infections within hospital settings, and the imperative to uphold stringent infection control protocols.

Antimicrobial Resistance Surveillance Market Size

Global Antimicrobial Resistance Surveillance Market – By Region

The in-depth research report on the Global Antimicrobial Resistance Surveillance Market covers various country-specific markets across five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America region holds the highest share in the Global Antimicrobial Resistance Surveillance Market. The region's dominance is attributed to its well-established healthcare systems and advanced laboratory facilities in the United States and Canada. These nations exhibit substantial investments in antimicrobial resistance (AMR) surveillance, with a specific focus on clinical diagnostics and data collection. The region's robust healthcare infrastructure and high standards of patient care contribute to the significant share held by clinical diagnostics in North America. Notably, the Centers for Disease Control and Prevention (CDC) in the United States spearhead AMR surveillance efforts. Meanwhile, the Asia Pacific region is expected to witness the fastest growth rate during the forecast period. China, in particular, has made noteworthy investments in AMR surveillance, establishing a national data collection network. Collaboration with international organizations, such as the World Health Organization (WHO), further enhances the region's efforts. The Asia Pacific region, encompassing diverse healthcare systems and population sizes, including China and India, encounters distinct challenges, prompting an upsurge in public health surveillance initiatives facilitated by regional and global health organizations

Competitive Landscape

Major players operating in the Global Antimicrobial Resistance Surveillance Market include Becton, Dickinson and Company, Biomerieux, Thermo Fisher Scientific, Danaher, Luminex Corporation, Bruker, Bio-Rad, Qiagen, Abbott Laboratories, Roche Diagnostics, OpGen, Inc., Wolters Kluwer N.V., Lumed, BioSpace, and Cepheid. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

In August 2023 - The UK Government pledged GBP 210 million to combat antimicrobial resistance (AMR) in priority countries across Asia and Africa. The funding, part of The Fleming Fund’s global AMR surveillance program, will establish state-of-the-art laboratories, disease surveillance systems, and support workforce development. Aimed at identifying superbugs before they reach the UK, the investment includes 20,000 training sessions for laboratory staff and health professionals in 25 countries with high AMR threats. Additionally, over 200 Fleming Fund Scholarships will enhance expertise in AMR. The UK-India partnership, backed by a GBP 3 million investment, contributes to strengthening global efforts against the silent threat of AMR, which could cause ten million deaths by 2050 if left unchecked.
In April 2023 - BioMérieux and JMI Laboratories forged a six-year partnership to combat antimicrobial resistance (AMR). The collaboration seeks to assess and enhance the performance of rapid microbiology diagnostics, essential tools in the battle against AMR. BioMérieux, known globally for its diagnostic advancements, will collaborate with JMI, a leader in antimicrobial resistance monitoring studies. The partnership aims to continuously evaluate antimicrobial susceptibility testing results against evolving global data through JMI's SENTRY program, contributing to understanding resistance mechanisms and improving the detection of resistance factors worldwide.

Scope of the Report

Attributes	Details
Years Considered	Historical Data – 2019–2022 Base Year – 2022 Estimated Year – 2023 Forecast Period – 2023–2029
Facts Covered	Revenue in USD Billion
Market Coverage	North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Product/ Service Segmentation	Solution, Application, End User, Region
Key Players	Becton, Dickinson and Company, Biomerieux, Thermo Fisher Scientific, Danaher, Luminex Corporation, Bruker, Bio-Rad, Qiagen, Abbott Laboratories, Roche Diagnostics, OpGen, Inc., Wolters Kluwer N.V., Lumed, BioSpace, Cepheid

By Solution

Diagnostic kits
Diagnostic systems
Surveillance software
Services

By Application

Clinical Diagnostics
Public Health Surveillance

By End User

Hospitals & Clinics
Research & Academic Institutes

By Region

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Research Framework
1. Research Objective
2. Product Overview
3. Market Segmentation
Executive Summary
Global Antimicrobial Resistance Surveillance Market Insights
1. Industry Value Chain Analysis
2. DROC Analysis
  1. Growth Drivers
    1. Increasing innovation in diagnostic technologies
    2. Increasing incidences of hospital-acquired infections
  2. Restraints
    1. High costs associated with antimicrobial resistance surveillance system and kits
    2. Technical challenges in the End User
  3. Opportunities
    1. Awareness initiatives for antimicrobial resistance and control
    2. Growth opportunities in emerging economies
  4. Challenges
    1. Complex regulatory framework
3. Technological Advancements/Recent Developments
4. Regulatory Framework
5. Porter’s Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of New Entrants
  4. Threat of Substitutes
  5. Intensity of Rivalry
Global Antimicrobial Resistance Surveillance Market Overview
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share and Forecast
  1. By Solution
    1. Diagnostic kits
    2. Diagnostic systems
    3. Surveillance software
    4. Services
  2. By Application
    1. Clinical Diagnostics
    2. Public Health Surveillance
    3. Other
  3. By End User
    1. Hospitals & Clinics
    2. Research & Academic Institutes
    3. Others
  4. By Region
    1. North America
    2. Europe
    3. Asia Pacific (APAC)
    4. Latin America (LATAM)
    5. Middle East and Africa (MEA)
North America Antimicrobial Resistance Surveillance Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Solution
  2. By Application
  3. By End User
  4. By Country
    1. United States
      1. By Solution
      2. By Application
      3. By End User
    2. Canada
      1. By Solution
      2. By Application
      3. By End User
Europe Antimicrobial Resistance Surveillance Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Solution
  2. By Application
  3. By End User
  4. By Country
    1. Germany
      1. By Solution
      2. By Application
      3. By End User
    2. United Kingdom
      1. By Solution
      2. By Application
      3. By End User
    3. Italy
      1. By Solution
      2. By Application
      3. By End User
    4. France
      1. By Solution
      2. By Application
      3. By End User
    5. Spain
      1. By Solution
      2. By Application
      3. By End User
    6. Belgium
      1. By Solution
      2. By Application
      3. By End User
    7. Russia
      1. By Solution
      2. By Application
      3. By End User
    8. The Netherlands
      1. By Solution
      2. By Application
      3. By End User
    9. Rest of Europe
      1. By Solution
      2. By Application
      3. By End User
Asia Pacific Antimicrobial Resistance Surveillance Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Solution
  2. By Application
  3. By End User
  4. By Country
    1. China
      1. By Solution
      2. By Application
      3. By End User
    2. India
      1. By Solution
      2. By Application
      3. By End User
    3. Japan
      1. By Solution
      2. By Application
      3. By End User
    4. South Korea
      1. By Solution
      2. By Application
      3. By End User
    5. Australia & New Zealand
      1. By Solution
      2. By Application
      3. By End User
    6. Indonesia
      1. By Solution
      2. By Application
      3. By End User
    7. Malaysia
      1. By Solution
      2. By Application
      3. By End User
    8. Singapore
      1. By Solution
      2. By Application
      3. By End User
    9. Vietnam
      1. By Solution
      2. By Application
      3. By End User
    10. Rest of APAC
      1. By Solution
      2. By Application
      3. By End User
Latin America Antimicrobial Resistance Surveillance Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Solution
  2. By Application
  3. By End User
  4. By Country
    1. Brazil
      1. By Solution
      2. By Application
      3. By End User
    2. Mexico
      1. By Solution
      2. By Application
      3. By End User
    3. Argentina
      1. By Solution
      2. By Application
      3. By End User
    4. Peru
      1. By Solution
      2. By Application
      3. By End User
    5. Rest of LATAM
      1. By Solution
      2. By Application
      3. By End User
Middle East & Africa Antimicrobial Resistance Surveillance Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Solution
  2. By Application
  3. By End User
  4. By Country
    1. Saudi Arabia
      1. By Solution
      2. By Application
      3. By End User
    2. UAE
      1. By Solution
      2. By Application
      3. By End User
    3. Qatar
      1. By Solution
      2. By Application
      3. By End User
    4. Kuwait
      1. By Solution
      2. By Application
      3. By End User
    5. South Africa
      1. By Solution
      2. By Application
      3. By End User
    6. Nigeria
      1. By Solution
      2. By Application
      3. By End User
    7. Algeria
      1. By Solution
      2. By Application
      3. By End User
    8. Rest of MEA
      1. By Solution
      2. By Application
      3. By End User
Competitive Landscape
1. List of Key Players and Their Offerings
2. Global Antimicrobial Resistance Surveillance Market Share Analysis, 2022
3. Competitive Benchmarking, By Operating Parameters
4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
Impact of Covid-19 on Global Antimicrobial Resistance Surveillance Market
Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
1. Becton, Dickinson and Company
2. Biomerieux
3. Thermo Fisher Scientific
4. Danaher
5. Luminex Corporation
6. Bruker
7. Bio-Rad
8. Qiagen
9. Abbott Laboratories
10. Roche Diagnostics
11. OpGen, Inc.
12. Wolters Kluwer N.V.
13. Lumed
14. BioSpace
15. Cepheid
16. Other Prominent Players
Key Strategic Recommendations
Research Methodology
1. Qualitative Research
  1. Primary & Secondary Research
2. Quantitative Research
3. Market Breakdown & Data Triangulation
  1. Secondary Research
  2. Primary Research
4. Breakdown of Primary Research Respondents, By Region
5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

List of Figures

Figure 1 Global Antimicrobial Resistance Surveillance Segmentation

Figure 2 Global Antimicrobial Resistance Surveillance Market Value Chain Analysis

Figure 3 Company Market Share Analysis, 2022

Figure 4 Global Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 5 Global Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 6 Global Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 7 Global Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 8 Global Antimicrobial Resistance Surveillance Market Share, By Region, By Value, 2019–2029

Figure 9 North America Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 10 North America Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 11 North America Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 12 North America Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 13 North America Antimicrobial Resistance Surveillance Market Share, By Country, By Value, 2019–2029

Figure 14 United States Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 15 United States Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 16 United States Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 17 United States Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 18 Canada Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 19 Canada Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 20 Canada Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 21 Canada Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 22 Europe Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 23 Europe Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 24 Europe Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 25 Europe Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 26 Europe Antimicrobial Resistance Surveillance Market Share, By Country, By Value, 2019–2029

Figure 27 Germany Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 28 Germany Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 29 Germany Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 30 Germany Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 31 United Kingdom Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 32 United Kingdom Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 33 United Kingdom Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 34 United Kingdom Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 35 Italy Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 36 Italy Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 37 Italy Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 38 Italy Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 39 France Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 40 France Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 41 France Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 42 France Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 43 Spain Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 44 Spain Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 45 Spain Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 46 Spain Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 47 Belgium Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 48 Belgium Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 49 Belgium Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 50 Belgium Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 51 Russia Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 52 Russia Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 53 Russia Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 54 Russia Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 55 The Netherlands Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 56 The Netherlands Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 57 The Netherlands Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 58 The Netherlands Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 59 Rest of Europe Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 60 Rest of Europe Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 61 Rest of Europe Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 62 Rest of Europe Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 63 Asia Pacific Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 64 Asia Pacific Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 65 Asia Pacific Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 66 Asia Pacific Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 67 Asia Pacific Antimicrobial Resistance Surveillance Market Share, By Country, By Value, 2019–2029

Figure 68 China Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 69 China Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 70 China Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 71 China Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 72 India Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 73 India Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 74 India Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 75 India Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 76 Japan Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 77 Japan Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 78 Japan Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 79 Japan Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 80 South Korea Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 81 South Korea Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 82 South Korea Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 83 South Korea Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 84 Australia & New Zealand Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 85 Australia & New Zealand Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 86 Australia & New Zealand Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 87 Australia & New Zealand Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 88 Indonesia Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 89 Indonesia Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 90 Indonesia Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 91 Indonesia Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 92 Malaysia Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 93 Malaysia Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 94 Malaysia Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 95 Malaysia Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 96 Singapore Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 97 Singapore Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 98 Singapore Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 99 Singapore Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 100 Vietnam Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 101 Vietnam Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 102 Vietnam Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 103 Vietnam Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 104 Rest of APAC Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 105 Rest of APAC Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 106 Rest of APAC Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 107 Rest of APAC Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 108 Latin America Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 109 Latin America Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 110 Latin America Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 111 Latin America Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 112 Latin America Antimicrobial Resistance Surveillance Market Share, By Country, By Value, 2019–2029

Figure 113 Brazil Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 114 Brazil Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 115 Brazil Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 116 Brazil Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 117 Mexico Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 118 Mexico Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 119 Mexico Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 120 Mexico Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 121 Argentina Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 122 Argentina Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 123 Argentina Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 124 Argentina Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 125 Peru Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 126 Peru Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 127 Peru Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 128 Peru Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 129 Rest of LATAM Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 130 Rest of LATAM Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 131 Rest of LATAM Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 132 Rest of LATAM Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 133 Middle East and Africa Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 134 Middle East and Africa Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 135 Middle East and Africa Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 136 Middle East and Africa Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 137 Middle East and Africa Antimicrobial Resistance Surveillance Market Share, By Country, By Value, 2019–2029

Figure 138 Saudi Arabia Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 139 Saudi Arabia Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 140 Saudi Arabia Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 141 Saudi Arabia Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 142 UAE Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 143 UAE Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 144 UAE Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 145 UAE Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 146 Qatar Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 147 Qatar Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 148 Qatar Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 149 Qatar Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 150 Kuwait Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 151 Kuwait Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 152 Kuwait Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 153 Kuwait Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 154 South Africa Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 155 South Africa Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 156 South Africa Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 157 South Africa Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 158 Nigeria Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 159 Nigeria Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 160 Nigeria Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 161 Nigeria Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 162 Algeria Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 163 Algeria Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 164 Algeria Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 165 Algeria Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Figure 166 Rest of MEA Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Figure 167 Rest of MEA Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Figure 168 Rest of MEA Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Figure 169 Rest of MEA Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

List of Tables

Table 1 Global Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 2 Global Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 3 Global Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 4 Global Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 5 Global Antimicrobial Resistance Surveillance Market Share, By Region, By Value, 2019–2029

Table 6 North America Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 7 North America Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 8 North America Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 9 North America Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 10 North America Antimicrobial Resistance Surveillance Market Share, By Country, By Value, 2019–2029

Table 11 United States Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 12 United States Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 13 United States Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 14 United States Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 15 Canada Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 16 Canada Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 17 Canada Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 18 Canada Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 19 Europe Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 20 Europe Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 21 Europe Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 22 Europe Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 23 Europe Antimicrobial Resistance Surveillance Market Share, By Country, By Value, 2019–2029

Table 24 Germany Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 25 Germany Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 26 Germany Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 27 Germany Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 28 United Kingdom Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 29 United Kingdom Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 30 United Kingdom Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 31 United Kingdom Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 32 Italy Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 33 Italy Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 34 Italy Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 35 Italy Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 36 France Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 37 France Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 38 France Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 39 France Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 40 Spain Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 41 Spain Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 42 Spain Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 43 Spain Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 44 Belgium Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 45 Belgium Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 46 Belgium Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 47 Belgium Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 48 Russia Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 49 Russia Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 50 Russia Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 51 Russia Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 52 The Netherlands Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 53 The Netherlands Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 54 The Netherlands Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 55 The Netherlands Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 56 Rest of Europe Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 57 Rest of Europe Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 58 Rest of Europe Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 59 Rest of Europe Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 60 Asia Pacific Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 61 Asia Pacific Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 62 Asia Pacific Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 63 Asia Pacific Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 64 Asia Pacific Antimicrobial Resistance Surveillance Market Share, By Country, By Value, 2019–2029

Table 65 China Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 66 China Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 67 China Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 68 China Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 69 India Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 70 India Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 71 India Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 72 India Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 73 Japan Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 74 Japan Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 75 Japan Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 76 Japan Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 77 South Korea Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 78 South Korea Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 79 South Korea Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 80 South Korea Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 81 Australia & New Zealand Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 82 Australia & New Zealand Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 83 Australia & New Zealand Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 84 Australia & New Zealand Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 85 Indonesia Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 86 Indonesia Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 87 Indonesia Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 88 Indonesia Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 89 Malaysia Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 90 Malaysia Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 91 Malaysia Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 92 Malaysia Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 93 Singapore Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 94 Singapore Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 95 Singapore Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 96 Singapore Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 97 Vietnam Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 98 Vietnam Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 99 Vietnam Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 100 Vietnam Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 101 Rest of APAC Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 102 Rest of APAC Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 103 Rest of APAC Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 104 Rest of APAC Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 105 Latin America Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 106 Latin America Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 107 Latin America Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 108 Latin America Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 109 Latin America Antimicrobial Resistance Surveillance Market Share, By Country, By Value, 2019–2029

Table 110 Brazil Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 111 Brazil Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 112 Brazil Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 113 Brazil Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 114 Mexico Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 115 Mexico Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 116 Mexico Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 117 Mexico Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 118 Argentina Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 119 Argentina Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 120 Argentina Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 121 Argentina Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 122 Peru Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 123 Peru Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 124 Peru Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 125 Peru Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 126 Rest of LATAM Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 127 Rest of LATAM Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 128 Rest of LATAM Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 129 Rest of LATAM Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 130 Middle East and Africa Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 131 Middle East and Africa Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 132 Middle East and Africa Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 133 Middle East and Africa Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 134 Middle East and Africa Antimicrobial Resistance Surveillance Market Share, By Country, By Value, 2019–2029

Table 135 Saudi Arabia Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 136 Saudi Arabia Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 137 Saudi Arabia Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 138 Saudi Arabia Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 139 UAE Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 140 UAE Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 141 UAE Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 142 UAE Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 143 Qatar Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 144 Qatar Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 145 Qatar Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 146 Qatar Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 147 Kuwait Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 148 Kuwait Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 149 Kuwait Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 150 Kuwait Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 151 South Africa Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 152 South Africa Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 153 South Africa Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 154 South Africa Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 155 Nigeria Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 156 Nigeria Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 157 Nigeria Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 158 Nigeria Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 159 Algeria Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 160 Algeria Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 161 Algeria Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 162 Algeria Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 163 Rest of MEA Antimicrobial Resistance Surveillance Market Size, By Value (USD Million), 2019–2029

Table 164 Rest of MEA Antimicrobial Resistance Surveillance Market Share, By Solution, By Value, 2019–2029

Table 165 Rest of MEA Antimicrobial Resistance Surveillance Market Share, By Application, By Value, 2019–2029

Table 166 Rest of MEA Antimicrobial Resistance Surveillance Market Share, By End User, By Value, 2019–2029

Table 167 Becton, Dickinson and Company Overview

Table 168 Becton, Dickinson and Company Financial Overview

Table 169 Biomerieux Company Overview

Table 170 Biomerieux Financial Overview

Table 171 Thermo Fisher Scientific Company Overview

Table 172 Thermo Fisher Scientific Financial Overview

Table 173 Danaher Company Overview

Table 174 Danaher Financial Overview

Table 175 Luminex Corporation Company Overview

Table 176 Luminex Corporation Financial Overview

Table 177 Bruker Company Overview

Table 178 Bruker Financial Overview

Table 179 Bio-Rad Company Overview

Table 180 Bio-Rad Financial Overview

Table 181 Qiagen Company Overview

Table 182 Qiagen Financial Overview

Table 183 Abbott Laboratories Company Overview

Table 184 Abbott Laboratories Financial Overview

Table 185 Roche Diagnostics Company Overview

Table 186 Roche Diagnostics Financial Overview

Table 187 OpGen, Inc. Company Overview

Table 188 OpGen, Inc. Financial Overview

Table 189 Wolters Kluwer N.V. Company Overview

Table 190 Wolters Kluwer N.V. Financial Overview

Table 191 Lumed Company Overview

Table 192 Lumed Financial Overview

Table 193 BioSpace Company Overview

Table 194 BioSpace Financial Overview

Table 195 Cepheid Company Overview

Table 196 Cepheid Financial Overview

Market Segmentation

No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Yes, I have read the privacy policy

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

1. What is the current market size of Global Antimicrobial Resistance Surveillance Market?

Ans: Global Antimicrobial Resistance Surveillance Market size was estimated at USD 5.71 billion in 2022.

2. What is the expected growth rate of Global Antimicrobial Resistance Surveillance Market during forecast period?

Ans: Global Antimicrobial Resistance Surveillance Market size is expected to grow at a CAGR of 5.6% during the forecast period between 2023 and 2029.

3. What is the expected market size of Global Antimicrobial Resistance Surveillance Market by 2029?

Ans: Global Antimicrobial Resistance Surveillance Market size is expected to reach a value of USD 7.92 billion by 2029.

4. What are the major factors driving the growth of Global Antimicrobial Resistance Surveillance Market?

Ans: Major factors driving the growth of the Global Antimicrobial Resistance Surveillance Market include an increasing innovation in diagnostic technologies and growing incidences of hospital-acquired infections.

5. Which is the dominant region in the Global Antimicrobial Resistance Surveillance Market?

Ans: North America holds the highest market share in the Global Antimicrobial Resistance Surveillance Market.

6. Which application segment holds the leadership position in the Global Antimicrobial Resistance Surveillance Market?

Ans: The clinical diagnostics segment accounts for a higher market share in the Global Antimicrobial Resistance Surveillance Market by application.

7. Which is the leading solution segment in the Global Antimicrobial Resistance Surveillance Market?

Ans: The diagnostic kits segment holds the highest market share in the Global Antimicrobial Resistance Surveillance Market by solution.

8. Name the key players in Global Antimicrobial Resistance Surveillance Market.

Ans: Key players in the Global Antimicrobial Resistance Surveillance Market include Becton, Dickinson and Company, Biomerieux, Thermo Fisher Scientific, Danaher, Luminex Corporation, Bruker, Bio-Rad, Qiagen, Abbott Laboratories, Roche Diagnostics, OpGen, Inc., Wolters Kluwer N.V., Lumed, BioSpace, and Cepheid.

PLACE AN ORDER

SINGLE USER LICENSE
$ 3637.5 ~~$ 4850~~
GROUP LICENSE
$ 4312.5 ~~$ 5750~~
ENTERPRISE LICENSE
$ 6112.5 ~~$ 8150~~
EXCEL DATA PACK
$ 2437.5 ~~$ 3250~~

ENQUIRE BEFORE PURCHASE

RELATED REPORTS

WHY CHOOSE US

24/7 Research Support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Custom Research Service

Ask the Analyst to customize an exclusive study to serve your research needs
Quality & Accuracy

Ask the Analyst to customize an exclusive study to serve your research needs
Data Visualization

As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.

Antimicrobial Resistance Surveillance Market

Report Overview

Market Segmentation

To request a free sample copy of this report, please complete the form below.

Frequently Asked Questions (FAQs):

PLACE AN ORDER

RELATED REPORTS

WHY CHOOSE US

24/7 Research Support

Custom Research Service

Quality & Accuracy

Data Visualization

Information security